Welcome to Mediso

Please select your region:

North America
Europe

Please select your language:

Go

About us

Since 1990

Mediso Medical Imaging Systems with headquarters in Budapest is a dynamic supplier of Nuclear Medicine and modern Hybrid Imaging techniques to the health care and medical research institutions of the world. The company was founded in 1990 by experts of the largest research and manufacturing company of the region which has been engaged of nuclear equipment manufacturing since 1960.

Company in numbers

Founded in

1990

Countries

100+

Offices

7

Get in touch

Employees

300+

Pre-Clinical Products

350+

Clinical Products

1400+

View products

Main activities of the company

  • Researching innovative clinical and pre-clinical imaging technologies
  • Developing leading edge clinical and pre-clinical systems
  • Manufacturing, selling and servicing imaging equipment
  • Providing diagnostic clinical services

Research and development

The business strength and perspective of Mediso is based on its R&D activity. To keep production on the leading edge continuous development of new products is a must. The company's declared aim is to develop competitive Nuclear Medicine and Hybrid Imaging equipment applying the most up-to-date technology. More than 50% of Mediso employees are engaged with R&D. (75% of Mediso employees hold higher academic degrees.)

A number of co-operations have been formed with hospitals, clinics and scientific institutions ensuring that the developed technology is in accordance with the needs of Mediso's clinical partners.

Production

The high quality unique systems designed with top level engineering and elaborated solid solutions are implemented to physical reality by the manufacturing section of Mediso. Carefully selected suppliers of quality parts and specialized high-precision subsystem manufacturers are key factors in the quality of final product integration.

Sales and After-sale Services

The Mediso-affiliated USA, German, Polish, Belgian, French and English subsidiaries and the wordwide distributor network ensures close contact with our customers and offers quick response for their requests. More than 1750 Mediso cameras are installed in more than 100 countries worldwide.

Diagnostic Clinical Services

Mediso operates two PET-CT and nuclear medicine centres at the University of Debrecen and in Budapest. The strong university and clinical background gives Mediso a first-hand clinical experience and important application feedback.

About us

Since 1990, Mediso is creating new technologies, and molecular imaging systems.

Clinical and pre-clinical solutions for hospitals, clinics and scientific institution

  • 2025

    Establishing Mediso Medical Imaging Systems France SAS

  • 2024

    Launch of TRIO-IQMAX and TRIO-TheraMAX SPECT/CT

  • 2023

    Introduction of nanoScan® P123S PET/CT

  • 2023

    Mediso receives FDA approval for InterView™ FUSION and InterView™ XP multimodality (PET/SPECT/MRI/CT) image processing and reporting software

  • 2022

    Establishing Mediso Medical Imaging Systems Belgium BV

  • 2022

    Acquisition of Bartec Technologies Ltd. and establishing Mediso Medical Imaging Systems UK Ltd. in 2023

  • 2022

    Introduction of PET insert for nanoScan® PET/MRI 7T

  • 2020

    New release of AnyScan® TRIO product family 2.0 with triple-detector SPECT and multi-pinhole (MPH) collimation technology available in SPECT, SPECT/CT and SPECT/CT/PET configurations

  • 2020

    New release of AnyScan® SPECT Flex based multimodality clinical imaging family 2.0

  • 2019

    Introduction of nanoScan® PET/MRI with 7T MRI

  • 2017

    Introduction of multi-pinhole (MPH) collimators on AnyScan® triple-detector SPECT camera

  • 2016

    Introduction of the nanoScan® PET/MRI 3T world’s first superconducting preclinical PET/MRI

  • 2016

    Introduction of AnyScan® triple-detector SPECT based SPECT/CT(/PET)

  • 2016

    Opening of new HQ in Budapest, Hungary

  • 2015

    Launch of nanoScan® SPECT/CT/PET

  • 2015

    Development of AnyScan® triple-detector SPECT family

  • 2015

    Introduction of AnyScan® dual-detector SPECT based SPECT/CT/PET

  • 2014

    Introduction of MultiScan™ LFER 150, submillimeter resolution PET/CT dedicated for NHP imaging

  • 2013

    Introduction of AnyScan® SPECT Flex based multimodality clinical imaging family 1.1

  • 2013

    Establishing Mediso USA in Boston, MA

  • 2012

    Launch of nanoScan® SPECT/CT

  • 2012

    Launch of AnyScan® Family 1.0 S SPECT with FLEX

  • 2011

    Launch of nanoScan® PET/MRI 1T, world’s first ever commercial preclinical PET/MRI

  • 2009

    Introduction of AnyScan® S SPECT

  • 2009

    Launch of preclinical nanoScan® PET/CT

  • 2008

    Introduction of AnyScan® 1.0 multimodality clinical imaging family

  • 2007

    Production of the first Mediso clinical SPECT/CT (DHV-CT). Mediso begins its NM clinical diagnostic service with the acquisition of ScanoMed Ltd.

  • 2006

    Launch of the first Mediso InterView™ XP and InterView™ Fusion multimodality workstation

  • 2006

    Introduction of Nucline™ TH-45(22/33)

  • 2006

    Launch of the first Mediso preclinical system, NanoSPECT/CT

  • 2005

    Establishing Mediso GmbH in Munster, Germany

  • 2005

    Introduction of Cardio Desk

  • 2004

    Introduction of Cardio C

  • 2003

    Introduction of Cardio SPECT D90

  • 2000

    Launch of the Nucline™ SPIRIT DH-V variable angle dual head camera

  • 1998

    Introduction of the Nucline™ X-ring/4R, 4-detector dedicated brain SPECT

  • 1998

    Mediso acquired the NM profile of Gamma Works

  • 1996

    Launch of the first SPECT camera, the Nucline™ X-Ring-R

  • 1996

    Introduction of Nucline™ AP gamma camera

  • 1994

    Introduction of the first Mediso gamma camera

  • 1991

    Launch of DIAG-AT ×86, the first Mediso evaluation software

  • 1990

    Mediso was founded

  • 1972

    Gamma Works released its first NM imager with digital processing

  • 1943

    George Hevesy received Nobel Prize for nuclear tracer theory